Frontotemporal Dementia: A Rare but Impactful Journey (and Why Canada Needs More Support)
- Feb 24
- 3 min read
When most people think of dementia, conditions like Alzheimer’s disease come to mind first. But lurking in the shadows of public awareness is a set of less common, yet deeply impactful diseases collectively known as frontotemporal dementia (FTD). These conditions are rare, often misunderstood, and critically they are demanding more attention from health systems, caregivers, and policymakers across Canada.
What Is Frontotemporal Dementia?
Frontotemporal dementia is not a single disease, but rather a group of disorders that affect the frontal and temporal lobes of the brain, the regions most associated with personality, behaviour, judgement, and language processing. Unlike the memory-dominant picture many people associate with dementia, FTD often begins with changes in personality, behaviour, and communication, making early symptoms harder to recognize and diagnose.
FTD can present in several ways, including:
Behavioural changes (e.g., disinhibition, apathy, compulsive behaviour)
Language difficulties (primary progressive aphasia)
Motor symptoms (in some subtypes)
Because it often strikes people under age 65, it’s also the most common form of young-onset dementia, affecting younger adults in the peak of their personal and professional lives.
How Rare Is It?
Although “rare” can feel abstract, the numbers help put it in perspective. Researchers estimate that about 10% of all dementia cases are frontotemporal dementia, a small slice of the overall dementia pie, but significant given the profound impact on individuals and families.
To frame that in context:
In Canada, dementia prevalence is rising rapidly, with hundreds of thousands of Canadians living with some form of dementia today and numbers projected to nearly double by 2030 and continue rising through 2050.
While Alzheimer’s disease remains far more common, FTD’s share is especially high among younger adults with dementia, accounting for up to 20% of “young-onset” cases.
Put simply: even though FTD affects a minority of people with dementia, it disproportionately affects younger adults and their working families, which carries unique social and economic consequences.
Why Does Rarity Matter?
Being rare isn’t just a clinical label — it has real-world implications:
1. Delays in Diagnosis
Many physicians are trained to spot typical Alzheimer’s symptoms. Because FTD often looks different (e.g., personality changes rather than memory loss), people can go years without a proper diagnosis, leaving families without answers or appropriate care plans.
2. Limited Resources and Support
Across Canada, many dementia supports from educational materials to community programs are focused on Alzheimer’s and memory decline. FTD’s behavioural and speech challenges often fall outside these typical care models, leaving families without targeted guidance. While Alzheimer societies across provinces offer some FTD information and support, families often describe gaps in practical resources, specialist care, and community services.
3. Financial and Caregiver Strain
Caregiver responsibilities in dementia are already intense in Canada, unpaid caregivers provide hundreds of millions of hours of care each year, often at great personal cost. Without dementia-specific supports tailored to FTD, families shoulder more stress, isolation, and burnout.
Gaps in the Canadian System
Canada has a national dementia strategy that acknowledges the need for better training, information, and caregiver support. However, specific references to rarer dementias like FTD are sparse, and implementation varies widely by province.
What many families report especially in online forums and caregiver communities are real challenges such as:
Long wait times for specialist assessments (e.g., neuropsychologists or neurologists familiar with FTD)
Difficulty accessing community support programs that understand behavioural and communication challenges
Limited public coverage for ongoing occupational or behavioural therapies
A Call for Awareness and Action
FTD may be rare, but its impact is anything but small. People living with frontotemporal dementia and their caregivers need:
Earlier, more accurate diagnosis paths
Healthcare providers trained in atypical dementias
Resources tailored to behavioural and communication needs
Financial and community support that recognizes young-onset caregiving challenges
Raising awareness through education, advocacy, and funding is essential. More research, better training, and expanded services can make a meaningful difference not just for the thousands living with FTD in Canada today, but for the millions who will be affected by dementia of all types in the decades ahead.




